Outreach management of people with chronic neurological disability.

ISRCTN ISRCTN85664035
DOI https://doi.org/10.1186/ISRCTN85664035
Secondary identifying numbers NYRHA WJML r135/05292
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
17/09/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Michael Barnes
Scientific

Newcastle City Health NHS Trust
Hunters Moor Rehabilitation Centre
Hunters Road
Newcastle upon Tyne
NE2 4NR
United Kingdom

Phone +44 (0)191 261 0895
Email m.p.barnes@ncl.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesA properly trained outreach nurse practitioner can provide a service that is as good as or better than that provided at a hospital outpatient clinic for people with chronic neurological disability.
The pilot population that is to be used to test this hypothesis is individuals with Parkinson's disease and dystonia attending Hunters Moor Regional Rehabilitation Centre in Newcastle upon Tyne. All patients attending the movement disorder clinic at Hunters Moor will be eligible for participation in the study.
We anticipate the hypothesis will be proven and that a properly trained nurse practitioner is able to provide a more satisfactory support service for people with the pilot condition both from the patients and general practitioners perspectives. If the hypothesis is proven the project will benefit the NHS as the patient will not need to make unnecessary journeys to hospital, the primary care team will be involved more effectively in the management of the individual, the specialist will see individuals at the time when such referral is required and the purchaser should get better value for money.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedParkinson's disease
InterventionAfter informed consent patients will be randomly divided into two groups with approximately 75 individuals in each group.

1. Standard attendance of outpatients
This group will continue to attend regular outpatient assessment at Hunters Moor as previously.

2. Visited at home by an outreach nurse practitioner
This group will not attend outpatients but will be visited at home by an outreach nurse practitioner. The group will have regular access to the nurse practitioner who will act a primary contact point for the disabled person and the family. The nurse practitioner will be responsible for liaison with the general practitioner and primary care team and for referral to the hospital consultant and members of the multi-disciplinary rehabilitation team as necessary. The consultant and multi-disciplinary team members will be able to assess the client and carer either at home or in the hospital. The nurse practitioner, within agreed protocols, would advise the patient on adjusting drug dosages and be responsible for the administration of botulinum toxin injections for individuals with dystonia.
The practitioner will provide educational material, advice and ongoing support for the patient and carer.
Intervention typeOther
Primary outcome measureThe effectiveness of this model of care will be assessed by a number of means including
1. Assessment of disability status measured by a number of appropriate scales
1.1. general practitioner and primary care team satisfaction questionnaires
1.2. comparison of attendances at hospital and general practitioner
1.3. record of complications
1.4. record of drug and other medical management employed during the study period
2. Satisfaction questionnaires will be administered to the patient and carer and their psychological status will also be measured using the General Health Questionnaire.
3. A brief questionnaire will be designed that records the extent and level of knowledge and understanding of the disease and associated disabilities. This questionnaire will be administered to the client and carer.
4. An economic analysis will also be undertaken of the costs involved in both arms of the study.
Secondary outcome measuresNot provided at time of registration
Overall study start date08/01/1995
Completion date31/07/1997

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Patients attending the movement disorder clinic at Hunters Moor
2. Being treated for Parkinson's and dystonia
3. Informed consent
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment08/01/1995
Date of final enrolment31/07/1997

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Newcastle City Health NHS Trust
Newcastle upon Tyne
NE2 4NR
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive Northern and Yorkshire (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2001 Yes No